MIRA PHARMACEUTICALS, INC. Quarterly Liabilities in USD from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Mira Pharmaceuticals, Inc. quarterly Liabilities history and growth rate from Q4 2022 to Q2 2024.
  • Mira Pharmaceuticals, Inc. Liabilities for the quarter ending June 30, 2024 was $797K, a 69.7% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $797K -$1.83M -69.7% Jun 30, 2024 10-Q/A 2024-08-16
Q1 2024 $652K Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $558K -$896K -61.6% Dec 31, 2023 10-Q/A 2024-08-16
Q3 2023 $903K Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $2.63M Jun 30, 2023 10-Q 2023-09-15
Q4 2022 $1.45M Dec 31, 2022 10-K 2024-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.